Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Milestone Scientific (MLSS) Equity Income (2016 - 2021)

Milestone Scientific (MLSS) has disclosed Equity Income for 11 consecutive years, with $407050.0 as the latest value for Q4 2021.

  • Quarterly Equity Income rose 315.84% to $407050.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $407050.0 through Sep 2022, up 711.42% year-over-year, with the annual reading at $242589.0 for FY2021, 147.83% up from the prior year.
  • Equity Income hit $407050.0 in Q4 2021 for Milestone Scientific, up from -$69905.0 in the prior quarter.
  • In the past five years, Equity Income ranged from a high of $407050.0 in Q4 2021 to a low of -$95857.0 in Q2 2021.
  • Historically, Equity Income has averaged $36221.6 across 5 years, with a median of $23842.5 in 2017.
  • Biggest five-year swings in Equity Income: soared 408.35% in 2018 and later plummeted 126.0% in 2019.
  • Year by year, Equity Income stood at -$91569.0 in 2017, then surged by 101.79% to $1635.0 in 2018, then skyrocketed by 1870.95% to $32225.0 in 2019, then surged by 203.76% to $97887.0 in 2020, then skyrocketed by 315.84% to $407050.0 in 2021.
  • Business Quant data shows Equity Income for MLSS at $407050.0 in Q4 2021, -$69905.0 in Q3 2021, and -$95857.0 in Q2 2021.